Stocks · Healthcare · Medical - Healthcare Information Services
Definitive Healthcare Corp. DH
$0.93 -0.30% Close, Oct 2, 2026 · NASDAQ · Market cap $98.5M
High qualityWeak trendHigh risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to 67.4% from -209.8% a year earlier.
- Over the past year the stock returned -73.8%, behind the S&P 500 by 88.9 percentage points.
- The stock is 73% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 23%
- FCF growth (TTM, YoY)Bottom 18%
- Revenue growth, 3-year CAGRBottom 31%
- Revenue growth accelerationBottom 40%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 2%
- Gross marginTop 40%
- Operating marginTop 1%
- Accruals (lower is better)Top 4%
- Interest coverTop 13%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 3%
- Free-cash-flow yieldTop 2%
- EBITDA / enterprise valueBottom 1%
- Sales / enterprise valueTop 3%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 2%
- 6-month returnBottom 28%
- 1-year return vs S&P 500Bottom 2%
- Distance from 52-week highBottom 6%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 18%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 1%
- Upside to consensus price targetBottom 34%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 21%
- Maximum drawdown, 3 yearsBottom 7%
- Beta vs S&P 500 (lower is better)Bottom 31%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -3.9% | -5.0% | ↓ |
| Gross margin | 76.4% | 71.7% | ↓ |
| Operating margin | -209.8% | 67.4% | ↑ |
| FCF margin | 20.9% | 12.3% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -5.0% | -3.9% | ↓ | Bottom 23% |
| Gross margin | 71.7% | 76.4% | ↓ | Top 40% |
| Operating margin | 67.4% | -209.8% | ↑ | Top 1% |
| Net margin | -72.3% | -124.4% | ↑ | — |
| Free-cash-flow margin | 12.3% | 20.9% | ↓ | — |
| Return on invested capital | 40.8% | — | Top 2% | |
| Revenue growth, 3-year CAGR | 2.7% | — | Bottom 31% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -42.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 10.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -11.8 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 14.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 12.25%
- Shareholder yield
- 12.25%
- Share count change, 1 year
- -0.9%
- Share count change, 3-year CAGR
- -1.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +33.4%
- Average 2-day reaction, last 8
- -0.8%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $1.20
- Target vs current price
- +28.6%
- Analysts with a rating
- 15
- Share rating Buy or Strong Buy
- 20%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | +17.1% | -2.1% | -10.4% | +47.2% | — |
| May 7, 2026 | +100.0% | -2.4% | -6.2% | -4.0% | -25.9% |
| Feb 26, 2026 | +0.0% | -0.7% | -13.5% | -22.7% | -41.8% |
| Nov 6, 2025 | +16.7% | -2.6% | +0.0% | -5.9% | -20.2% |
| Aug 7, 2025 | +40.0% | +1.0% | +0.3% | +2.0% | -31.8% |
| May 8, 2025 | +150.0% | +3.3% | +25.4% | +30.9% | +41.2% |
| Feb 27, 2025 | +14.3% | -3.5% | -45.7% | -42.5% | -38.6% |
| Nov 7, 2024 | +25.0% | +0.2% | +5.1% | +6.3% | +21.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | $0.05 | $0.04 | +17.1% | $55.2M |
| May 7, 2026 | $0.06 | $0.03 | +100.0% | $55.9M |
| Feb 26, 2026 | $0.06 | $0.06 | +0.0% | $61.5M |
| Nov 6, 2025 | $0.07 | $0.06 | +16.7% | $60.0M |
| Aug 7, 2025 | $0.07 | $0.05 | +40.0% | $60.8M |
| May 8, 2025 | $0.05 | $0.02 | +150.0% | $59.2M |
| Feb 27, 2025 | $0.08 | $0.07 | +14.3% | $62.3M |
| Nov 7, 2024 | $0.10 | $0.08 | +25.0% | $62.7M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 4.8× | — | — | — |
| EV / Sales | 0.41× | — | — | Top 3% |
| Free-cash-flow yield | 29.00% | — | — | Top 2% |
| Earnings yield | -171.43% | — | — | Bottom 3% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 28
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +10.5%
- 200-day average slope (20 days)
- -11.5%
- Distance from 50-day average
- +12.0%
- Distance from 200-day average
- -24.0%
- RSI (14)
- 51.6
- Relative volume
- 0.22×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 76.0%
- Volatility vs own 5-year history
- 69th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.54
- Correlation with S&P 500
- 0.33
- Current drawdown from 1-year high
- -72.7%
- Maximum drawdown, 3 years
- -93.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 17, 2021 | Jun 25, 2026 | -98.7% | 1196 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $98.5M
- EPS, diluted (TTM)
- -$1.60
- Revenue (TTM)
- $232.7M
- 52-week range
- $0.61 – $3.58
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $166.2M | $222.7M | $251.4M | $252.2M | $241.5M |
| Gross profit | $125.5M | $180.0M | $203.9M | $197.5M | $183.3M |
| Operating income | -$27.3M | -$44.0M | -$329.8M | -$710.8M | -$20.6M |
| Net income | -$51.9M | -$7.2M | -$202.4M | -$413.1M | -$138.9M |
| EPS (diluted) | -$0.19 | -$0.07 | -$1.79 | -$3.54 | -$1.30 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $62.7M | $62.3M | $59.2M | $60.8M | $60.0M | $61.5M | $55.9M | $55.2M |
| Net income | -$130.9M | -$59.1M | -$107.2M | -$7.6M | -$14.8M | -$9.3M | -$138.6M | -$5.4M |
| EPS (diluted) | -$1.12 | -$0.51 | -$0.95 | -$0.07 | -$0.14 | -$0.09 | -$1.32 | -$0.05 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $25.2M | $35.6M | $41.2M | $58.2M | $53.8M |
| Capital expenditure | -$6.7M | -$8.3M | -$3.0M | -$12.3M | -$16.7M |
| Free cash flow | $18.5M | $27.3M | $38.2M | $45.9M | $37.1M |
| Dividends paid | -$8.1M | -$12.9M | -$12.3M | -$5.1M | -$3.1M |
| Net share buybacks | $603.2M | -$1.7M | -$30,000 | -$22.4M | -$49.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $183.6M
- Total assets
- $496.8M
- Total liabilities
- $309.0M
- Total debt
- $167.1M
- Net debt
- -$3.8M
- Shareholders’ equity
- $144.7M
As of Jun 30, 2026 (filed Aug 10, 2026).
Short interest
- Shares sold short
- 1,820,139
- Days to cover
- 1.32
- Change vs previous report
- -8.3%
FINRA short interest, settlement date Sep 15, 2026.